Skip to content

Application of transnasal humidified rapid-insufflation ventilatory exchange in painless gastroscopy

Application of transnasal humidified rapid-insufflation ventilatory exchange in painless gastroscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053816
Enrollment
Unknown
Registered
2021-11-29
Start date
2020-07-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental group:Fast-Filling Nasal Humidification High Flow Ventilation

Sponsors

Nanjing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who plan to undergo painless gastroscopy; 2. Aged 18 to 65 years; 3. ASA classification I-II; 4. Patients who voluntarily tested and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. There are coagulation disorders or upper respiratory tract bleeding, severe cardiovascular, pulmonary, liver or kidney diseases; 2. Patients with oral, nasal or throat infections or tumors; 3. A history of difficult intubation anesthesia, severe sleep apnea syndrome [apnea/apnea-hypopnea index (AHI)>40]; 4. Patients who are allergic to propofol, eggs, soybeans or egg whites; 5. Those without escort or guardian; 6. Patients who participated in other studies within 30 days; 7. Other researchers think that it is not suitable to participate in this research.

Design outcomes

Primary

MeasureTime frame
Perioperative hypoxia related adverse events;

Secondary

MeasureTime frame
General adverse events except hypoxia;

Countries

China

Contacts

Public ContactWang Xiaoliang

Nanjing First Hospital

wxl145381@163.com+86 13776615743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026